Becton Dickinson, US0718131099

Baxter International Stock - Thursday technicals and trading picture

18.06.2026 - 21:48:11 | ad-hoc-news.de

Baxter International stock trades in a tight range on Thursday, with investors watching key technical levels after recent portfolio moves and ahead of the next earnings date.

Becton Dickinson, US0718131099
Becton Dickinson, US0718131099

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:40 UTC. Details in the imprint.

Baxter International (US0718131099) is trading sideways on Thursday, with the shares moving in a narrow band as investors focus on key chart levels and the company’s reshaped medtech profile. The picture fits a broader market session marked by modest moves in healthcare names.

Go deeper

All news and key data on Baxter International stock

Historical prices, corporate news and regulatory filings provide additional context for Baxter’s trading pattern and technical setup.

What recent filings show

Baxter International Inc. continues to present its financials largely from continuing operations after the divestiture of its Kidney Care business and related separation steps in 2025 and early 2026, according to recent investor materials. Company IR information

In its most recent annual and quarterly disclosures, Baxter highlighted core franchises in infusion systems, clinical nutrition, pharmaceuticals and patient-support systems as the drivers of its revenue base while it streamlines its portfolio and reduces leverage. SEC filings overview

Thursday’s chart and technical picture

On Thursday, Baxter shares trade on the New York Stock Exchange in a tight intraday range, reflecting muted volume and a lack of fresh company-specific catalysts in the medtech space compared with more volatile technology names. NYSE quote data

The stock’s current level keeps it roughly in line with recent weeks’ trading band, leaving the medium-term technical picture largely unchanged and putting the focus on the next earnings update as a potential trigger for a break above or below recent support zones.

How the business generates revenue

Baxter makes most of its money by supplying hospitals and other care settings with infusion pumps, IV sets, injectable drugs, clinical nutrition solutions and operating-room equipment, positioning the group as a diversified provider of critical-care and perioperative products rather than a single-product story.

Where the stock trades today

The shares of Baxter International (US0718131099) trade on the New York Stock Exchange at $42.10 as of 06/18/2026, 19:40 UTC.

Key facts on Baxter International stock

  • Company: Baxter International Inc.
  • ISIN: US0718131099
  • WKN: 856831
  • Ticker: BAX
  • Venue: NYSE
  • Price (as of 06/18/2026, 19:40 UTC): 42.10 USD
  • Market cap: 21,500,000,000 USD (as of 06/18/2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: S&P 500
  • Next earnings date: 07/30/2026

More on Baxter International stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US0718131099 | BECTON DICKINSON | boerse | 69576421 | bgmi